Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Nicola J Rowbotham"'
Autor:
Vinishaa Premakumar, Vigilius Gleetus, Zoe Elliott, Bu Hayee, Nicola J Rowbotham, Bethinn Evans, Helen Barr, Siobhán B Carr, Daniel Peckham, Alexander Horsley, Alan R Smyth, Natalie Goodchild, Rebecca J Calthorpe
Publikováno v:
NIHR Open Research, Vol 3 (2024)
Background Gastrointestinal symptoms in cystic fibrosis (CF) are common and intrusive to daily life. Relieving gastrointestinal symptoms was identified as an important research priority and previously explored in an international survey in 2018. Howe
Externí odkaz:
https://doaj.org/article/bf67e4efe61d45ee8b61970134c74365
Autor:
Vinuja Premakumar, Vigilius Gleetus, Zoe Elliott, Bu Hayee, Nicola J Rowbotham, Bethinn Evans, Helen Barr, Siobhán B Carr, Daniel Peckham, Alexander Horsley, Alan R Smyth, Natalie Goodchild, Rebecca J Calthorpe
Publikováno v:
NIHR Open Research, Vol 3 (2023)
Background: Gastrointestinal symptoms in cystic fibrosis (CF) are common and intrusive to daily life. Relieving gastrointestinal symptoms was identified as an important research priority and previously explored in an international survey in 2018. How
Externí odkaz:
https://doaj.org/article/30e967ec12354b958c816835c3f0b6f4
Publikováno v:
Breathe, Vol 18, Iss 2 (2022)
Healthcare is a major global industry accounting for a significant proportion of government spending. Drug and medical device manufacturers are publicly traded companies with a responsibility to their shareholders to maximise profits by increasing sa
Externí odkaz:
https://doaj.org/article/a8c4724aab8f4f59a905f72e8befa2b9
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
Inhaled antibiotics are commonly used to treat persistent airway infection with Pseudomonas aeruginosa that contributes to lung damage in people with cystic fibrosis. Current guidelines recommend inhaled tobramycin for individuals with cystic fibrosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f77ac598f77f210906634372a361e8b
https://pubmed.ncbi.nlm.nih.gov/29607494
https://pubmed.ncbi.nlm.nih.gov/29607494
Autor:
Gwyneth Davies, Paul A Leighton, Alan R Smyth, Rebecca J Calthorpe, Sherie J Smith, Nicola J Rowbotham, Tracey Daniels, Zoe C Elliott
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Introduction “What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?” was identified as one of the James Lind Alliance Priority Setting Partnership’s top 10 resea
Externí odkaz:
https://doaj.org/article/cff6e14318ab4a90a79faca45fe6b1c7
Autor:
Michael P. Yanney, Andrew P. Prayle, Nicola J. Rowbotham, Miguel Kurc, Sean Tilbrook, Nabeel Ali
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Pulse transit time (PTT) is a non-invasive measure of arousals and respiratory effort for which we aim to identify threshold values that detect sleep disordered breathing (SDB) in children. We also compare the sensitivity and specificity
Externí odkaz:
https://doaj.org/article/c43a00c2a5454eda898b5b6c10c47e0b
Publikováno v:
Cochrane Database Syst Rev
BACKGROUND: Respiratory disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and many different therapies are used by people with CF in the management of respiratory problems. Bronchodilator therapy is used to relieve symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bdf09c4cb7d6b286a429543fcbb37ea
https://doi.org/10.1002/14651858.cd013666.pub2
https://doi.org/10.1002/14651858.cd013666.pub2
Autor:
Rebecca J Calthorpe, Natalie Goodchild, Vigilius Gleetus, Vinuja Premakumar, Bu Hayee, Zoe Elliott, Bethinn Evans, Nicola J Rowbotham, Siobhán B Carr, Helen Barr, Alexander Horsley, Daniel Peckham, Alan R Smyth
Publikováno v:
NIHR Open Research. 3:18
Background: Gastrointestinal symptoms in cystic fibrosis (CF) are common and intrusive to daily life. Relieving gastrointestinal symptoms was identified as an important research priority and previously explored in an international survey in 2018. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17643bdca2a0714504150177f4161fc3
https://doi.org/10.3310/nihropenres.13384.1
https://doi.org/10.3310/nihropenres.13384.1
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
Autor:
Zoe C Elliot, Alan R. Smyth, Paul Leighton, Katie Gathercole, Alistair Ja Duff, Nicola J. Rowbotham, O.C. Rayner, Tracey Daniels, Suja Chandran, Edward F. Nash, Sherie Smith, Sophie Herbert, Gwyneth Davies
Publikováno v:
Journal of Cystic Fibrosis. 19:499-502
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priority clinical research question was: "What are effective ways of simplifying the treatment burden of people with CF?" We aimed to summarise the lived exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa6c8482a48418eceb30d9a802e5461
https://doi.org/10.1016/j.jcf.2019.10.025
https://doi.org/10.1016/j.jcf.2019.10.025
Autor:
T. Daniels, Nicola J. Rowbotham
Publikováno v:
Pediatric Pulmonology. 57
Airway clearance has been an integral part of cystic fibrosis (CF) care for almost as long as CF has been identified as a condition. From diagnosis as a neonate through to end-of-life care, airway clearance is an everyday aspect of life, adding a con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045e4b3e36ac828621cda8fcdcb970ed
https://doi.org/10.1002/ppul.25734
https://doi.org/10.1002/ppul.25734